What is Dr Gregory Pamel?
Pamel Vision & Laser Group operates as a premier clinical entity specializing in high-acuity ophthalmological procedures, including LASIK, cataract surgery, and the management of complex conditions such as keratoconus and presbyopia. With a legacy spanning over two decades, the practice distinguishes itself through the integration of cutting-edge diagnostic and surgical technology. By maintaining a focus on patient-centric outcomes and clinical excellence, the organization has established a formidable reputation within the competitive New York City healthcare landscape, effectively bridging the gap between traditional eye care and innovative surgical intervention.
How much funding has Dr Gregory Pamel raised?
Dr Gregory Pamel has raised a total of $384K across 2 funding rounds:
Debt
$150K
Debt
$234K
Debt (2020): $150K with participation from PPP
Debt (2021): $234K led by PPP
Key Investors in Dr Gregory Pamel
PPP
Public-Private Partnership
What's next for Dr Gregory Pamel?
With the recent influx of capital, Dr Gregory Pamel is well-positioned to enhance its service delivery model and expand its technological infrastructure. The strategic deployment of these funds will likely focus on upgrading surgical suites and increasing capacity to meet the rising demand for specialized vision correction. As the practice navigates the complexities of the late-stage growth phase, the emphasis will remain on maintaining high-quality patient outcomes while exploring potential operational efficiencies. This financial backing provides the necessary runway to sustain long-term growth and reinforce the practice's status as a leader in the ophthalmology sector.
See full Dr Gregory Pamel company page
